Mayo Risk Score is not predictive of Cholangiocarcinoma associated with Primary Sclerosing Cholangitis.

被引:1
|
作者
Olivera, MA
McCashland, TM
Ruby, L
Rouillard, S
Somberg, K
Reddy, R
机构
[1] Univ Nebraska, Med Ctr, Liver Transplant Unit, Lincoln, NE 68583 USA
[2] Univ Calif San Francisco, UNMC, San Francisco, CA 94143 USA
[3] UCSF, Ctr Liver Dis, Miami, FL USA
关键词
D O I
10.1016/S0016-5085(98)85341-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
L0483
引用
下载
收藏
页码:A1316 / A1316
页数:1
相关论文
共 50 条
  • [21] Sclerosing cholangitis. Primary, autoimmune and secondary sclerosing diseases
    Weismueller, T. J.
    Strassburg, C. P.
    Manns, M. P.
    Lankisch, T. O.
    GASTROENTEROLOGE, 2012, 7 (06): : 483 - 492
  • [22] Cholangiocarcinoma is associated with a raised enhanced liver fibrosis score independent of primary sclerosing cholangitis
    Saffioti, Francesca
    Roccarina, Davide
    Vesterhus, Mette
    Hov, Johannes R.
    Rosenberg, William
    Pinzani, Massimo
    Pereira, Stephen P.
    Boberg, Kirsten M.
    Thorburn, Douglas
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2019, 49 (05)
  • [23] Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: The Mayo clinic experience.
    Kaya, M
    de Groen, PC
    Angulo, P
    Lindor, KD
    GASTROENTEROLOGY, 2000, 118 (04) : A1456 - A1456
  • [24] Primary sclerosing cholangitis and cholangiocarcinoma
    Lazaridis, Konstantinos N.
    Gores, Gregory J.
    SEMINARS IN LIVER DISEASE, 2006, 26 (01) : 42 - 51
  • [25] A Case of Intrahepatic Cholangiocarcinoma Associated with Primary Sclerosing Cholangitis
    Kanemitsu, Eisho
    Esaki, Minoru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (06) : 600 - 600
  • [26] Cholangiocarcinoma in primary sclerosing cholangitis
    Abbas G.
    Lindor K.D.
    Journal of Gastrointestinal Cancer, 2009, 40 (1-2) : 19 - 25
  • [27] Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
    Burak, K
    Angulo, P
    Pasha, TM
    Egan, K
    Petz, J
    Lindor, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2004, 99 (03): : 523 - 526
  • [28] Oral pirfenidone in the treatment of primary sclerosing cholangitis.
    Angulo, P
    MacCarty, RL
    Sylvestre, PB
    Jorgensen, RA
    LaRusso, NF
    Lindor, KD
    GASTROENTEROLOGY, 2000, 118 (04) : A1015 - A1015
  • [29] MICA and mice polymorphisms in primary sclerosing cholangitis.
    Kristine, W
    Anne, S
    Schrumpf, E
    Boberg, KM
    HEPATOLOGY, 2000, 32 (04) : 173A - 173A
  • [30] Coexisting primary biliary cholangitis, autoimmune hepatitis, and primary sclerosing cholangitis.
    Beretta-Piccoli, Benedetta Terziroli
    Mazzucchelli, Luca
    Mossi, Giuseppe
    Usai, Corrado
    Vergani, Diego
    Mieli-Vergani, Giorgina
    SWISS MEDICAL WEEKLY, 2018, 148 : 26S - 26S